These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29551582)

  • 1. Ki-67 as a Prognostic Marker in Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Ahn C; Jeong CW; Kwak C; Kim HH; Kim HS; Ku JH
    Clin Genitourin Cancer; 2018 Aug; 16(4):e831-e841. PubMed ID: 29551582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Overexpression of Ki-67 a Prognostic Biomarker of Upper Tract Urinary Carcinoma? A Retrospective Cohort Study and Meta-Analysis.
    Fan B; Zhang H; Jin H; Gai Y; Wang H; Zong H; Jin M; Yang H; Wan S; Zhu J; Xu S; Wang J; Yang D; Song X
    Cell Physiol Biochem; 2016; 40(6):1613-1625. PubMed ID: 28006766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Role of Ki-67/MIB-1 in Upper Urinary-Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis.
    Lei Y; Li Z; Qi L; Tong S; Li B; He W; Chen M
    J Endourol; 2015 Nov; 29(11):1302-8. PubMed ID: 26083161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes of Patients Undergoing Diagnostic Ureteroscopy Before Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinomas: A Systematic Review and Meta-Analysis.
    Liu Z; Zheng S; Li X; Guo S; Wang Y; Zhou F; Liu ZW
    J Laparoendosc Adv Surg Tech A; 2018 Nov; 28(11):1316-1325. PubMed ID: 29873581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.
    Seisen T; Granger B; Colin P; Léon P; Utard G; Renard-Penna R; Compérat E; Mozer P; Cussenot O; Shariat SF; Rouprêt M
    Eur Urol; 2015 Jun; 67(6):1122-1133. PubMed ID: 25488681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
    D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
    Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis.
    Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Jan; 8(5):7464-7476. PubMed ID: 27448978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.
    Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Khalil D; Kapur P; Shariat SF; Raj GV; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):54.e19-26. PubMed ID: 24360665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Effect of Sex on Outcomes after Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    Mori K; Mostafaei H; Enikeev DV; Lysenko I; Quhal F; Kimura S; Karakiewicz PI; Egawa S; Shariat SF
    J Urol; 2020 Jul; 204(1):58-62. PubMed ID: 31995432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of p53 on survival of upper urinary tract urothelial carcinoma: a systematic review and meta-analysis.
    Ku JH; Byun SS; Jeong H; Kwak C; Kim HH; Lee SE
    Clin Genitourin Cancer; 2013 Sep; 11(3):221-8. PubMed ID: 23357513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
    Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
    Guo RQ; Hong P; Xiong GY; Zhang L; Fang D; Li XS; Zhang K; Zhou LQ
    BJU Int; 2018 Feb; 121(2):184-193. PubMed ID: 29032580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the impact of different distal ureter management techniques during radical nephroureterectomy for primary upper urinary tract urothelial carcinoma on oncological outcomes: A systematic review and meta-analysis.
    Lai S; Guo R; Seery S; Wu P; Liu J; Zhang Y; Zhu S; Li X; Liu M; Wang J
    Int J Surg; 2020 Mar; 75():165-173. PubMed ID: 31978650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of tumor architecture in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A systematic review and meta-analysis.
    Zhao H; Zhang L; Wu B; Zha Z; Yuan J; Jiang Y; Feng Y
    Medicine (Baltimore); 2020 Sep; 99(37):e22176. PubMed ID: 32925787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial Carcinoma.
    Ikeda M; Matsumoto K; Sakaguchi K; Ishii D; Tabata KI; Kurosawa K; Urakami S; Okaneya T; Iwamura M
    Clin Genitourin Cancer; 2017 Oct; 15(5):556-562. PubMed ID: 28501481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.